White House unveils nine new drug-price deals with pharma firms
TL;DR Summary
The White House announced nine additional MFN-style drug-pricing deals with pharma firms (bringing total to 26) intended to lower prices for Medicaid and align U.S. prices with other wealthy nations; details are largely confidential, prompting calls from Democrats for transparency. The administration also highlights the Medicare GLP-1 Bridge Program, which has saved seniors money, and urges Congress to codify MFN pricing into permanent law.
Topics:nation#drug-pricing#glp-1-bridge-program#health-policy#medicaid#most-favored-nation#pharmaceutical-companies
- White House strikes new drug-pricing deals Politico
- Trump announces new drug pricing deals with 9 pharma companies NBC News
- Nine more drugmakers cut pricing deals with Trump Axios
- Trump administration announces drug pricing deals with CSL, Astellas and others Reuters
- Live updates: Donald Trump rolls out new lower drug prices; House returns from recess The Hill
Reading Insights
Total Reads
1
Unique Readers
18
Time Saved
6 min
vs 7 min read
Condensed
95%
1,284 → 64 words
Want the full story? Read the original article
Read on Politico